Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Cetuximab sarotalocan by Rakuten Medical for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
Cetuximab sarotalocan is under clinical development by Rakuten Medical and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC)....
Data Insights
Cetuximab sarotalocan by Rakuten Medical for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
Cetuximab sarotalocan is under clinical development by Rakuten Medical and currently in Phase III for Recurrent Head And Neck Squamous...